Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Chery A. Whipple"'
Publikováno v:
The Scientific World Journal, Vol 8, Pp 1250-1253 (2008)
The heparan sulfate proteoglycan, Glypican-1 (GPC1), significantly impacts the growth of pancreatic cancer cells in vivo and markedly attenuates tumor angiogenesis and metastasis in athymic mice. Interestingly, both cancer cell–derived and host-der
Externí odkaz:
https://doaj.org/article/86648448a7e34ac594a0a1aa7e53dde6
Autor:
Brock C. Christensen, Alissa A. Thomas, Arti B. Gaur, Marc S. Ernstoff, Gilbert J. Rahme, Camilo E. Fadul, Sandra E. Steel, Chery A. Whipple, Melissa C. Davis, Thomas H. Hampton, Jan L. Fisher, Lionel D. Lewis, Gregory J. Tsongalis
Publikováno v:
Cancer Immunology, Immunotherapy. 66:379-389
Vascular endothelial growth factor (VEGF), in addition to being pro-angiogenic, is an immunomodulatory cytokine systemically and in the tumor microenvironment. We previously reported the immunomodulatory effects of radiation and temozolomide (TMZ) in
Autor:
Alissa A. Thomas, Jan L. Fisher, Francine B. de Abreu, Michael B. Miller, C. Harker Rhodes, Joel A. Lefferts, Gilbert J. Rahme, Thomas H. Hampton, Chery A. Whipple, Camilo E. Fadul, Laura J. Tafe, Jonathan K. Kleen, Gregory J. Tsongalis, Heather A. Wishart, Tim Schwachula, Sven Olek, Marc S. Ernstoff, Udo Baron, Jiang Gui
Publikováno v:
Neuro-Oncology. 17:801-809
Immunotherapy is emerging as an effective new treatment for many cancers,1 but it has yet to translate into a proven clinical benefit for patients with glioblastoma.2 A purported limitation of applying immunotherapy to gliomas is the tumor-induced im
Autor:
Diane Mellinger, Laura J. Tafe, Jan L. Fisher, Gregory J. Tsongalis, Marc S. Ernstoff, Thomas H. Hampton, Camilo E. Fadul, Andrea Boni, Shaofeng Yan, Chery A. Whipple, Mary Jo Turk, David W. Mullins, Constance E. Brinckerhoff
Publikováno v:
Melanoma research. 26(3)
The advent of drugs targeting the mitogen-activated protein kinase (MAPK) pathway has markedly changed the treatment of advanced-stage melanoma harboring BRAF mutations. However, drug resistance, through mechanisms not well elucidated, often occurs.
Autor:
Chery A. Whipple, Murray Korc
Publikováno v:
Langenbeck's Archives of Surgery. 393:901-910
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer responsible for over 20% of deaths due to gastrointestinal malignancies. PDAC is usually diagnosed at an advanced stage which, in part, helps to explain its high resistance to chem
Autor:
Jason R. Gunn, Chery A. Whipple, Murray Korc, Martha E. Lopez, Alison L. Young, Takuma Aikawa, Arthur D. Lander
Publikováno v:
Aikawa, T; Whipple, CA; Lopez, ME; Gunn, J; Young, A; Lander, AD; et al.(2008). Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells. Journal of Clinical Investigation, 118(1), 89-99. doi: 10.1172/JCI32412. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2n50291v
Cells isolated from many types of human cancers express heparin-binding growth factors (HBGFs) that drive tumor growth, metastasis, and angiogenesis. The heparan sulfate proteoglycan glypican-1 (GPC1) is a coreceptor for HBGFs. Here we show that both
Publikováno v:
The Scientific World Journal, Vol 8, Pp 1250-1253 (2008)
Whipple, Chery A; Lander, Arthur D; & Korc, Murray. (2008). Discovery of a Novel Molecule that Regulates Tumor Growth and Metastasis. The Scientific World JOURNAL, 8, 1250-1253. doi: 10.1100/tsw.2008.152. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/0nt6161n
The Scientific World Journal
Whipple, Chery A; Lander, Arthur D; & Korc, Murray. (2008). Discovery of a Novel Molecule that Regulates Tumor Growth and Metastasis. The Scientific World JOURNAL, 8, 1250-1253. doi: 10.1100/tsw.2008.152. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/0nt6161n
The Scientific World Journal
The heparan sulfate proteoglycan, Glypican-1 (GPC1), significantly impacts the growth of pancreatic cancer cellsin vivoand markedly attenuates tumor angiogenesis and metastasis in athymic mice. Interestingly, both cancer cell–derived and host-deriv
Autor:
Chery A. Whipple
Publikováno v:
Cancer Cell & Microenvironment.
It was once believed that tumor growth, progression, and metastasis were intrinsically driven by the tumor. Instead, recent research has demonstrated that a solid tumor is surrounded by a complex matrix of cells, particularly fibroblasts, which suppo
Autor:
Thomas H. Hampton, Craig R. Tomlinson, Marc S. Ernstoff, Jan L. Fisher, Mary Jo Turk, David W. Mullins, Polina Shindiapina, Camilo E. Fadul, Chery A. Whipple
Publikováno v:
Journal of Clinical Oncology. 34:e13001-e13001
e13001Background: Melanoma progression is often associated with a mutation in the BRAF oncogene that promotes constitutive activation of the MAPK signaling cascade. Analysis of malignant transforma...
Publikováno v:
Oncogene
Pancreatic ductal adenocarcinomas (PDACs) exhibit multiple molecular alterations and overexpress heparin binding growth factors (HBGFs) and glypican-1 (GPC1), a heparan sulfate proteoglycan that promotes efficient signaling by HBGFs. It is not known,